Michael Berendt - Waters Independent Director
WAT Stock | USD 344.23 0.96 0.28% |
Director
Dr. Michael Joseph Berendt, Ph.D., is Independent Director of Waters Corporationrationration. Since December 2016, Dr. Berendt was a life sciences industry consultant. From November 2013 to November 2016, Dr. Berendt was the Chief Executive Officer and Chief Scientist of Telesta Therapeutics. From July 2011 to November 2013, Dr. Berendt was a life sciences industry consultant. From March 2006 to July 2011, Dr. Berendt served as the President and Chief Executive Officer of Aegera Therapeutics Inc. From August 2004 to December 2005, Dr. Berendt served as Managing Director of Research Corporation Technologies, Inc. From November 2000 to August 2004, Dr. Berendt served as Managing Director of AEA Investors LP. Dr. Berendt also worked for 18 years, from 1982 to 2000, in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporationrationration, and a Group Director of Drug Discovery at Pfizer, Inc since 1998.
Age | 71 |
Tenure | 26 years |
Professional Marks | Ph.D |
Address | 34 Maple Street, Milford, MA, United States, 01757 |
Phone | 508 478 2000 |
Web | https://www.waters.com |
Waters Management Efficiency
The company has Return on Asset of 0.1354 % which means that on every $100 spent on assets, it made $0.1354 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.7762 %, implying that it generated $0.7762 on every 100 dollars invested. Waters' management efficiency ratios could be used to measure how well Waters manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.23 in 2024, whereas Return On Assets are likely to drop 0.11 in 2024. At this time, Waters' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 89.2 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 719.7 M in 2024.Similar Executives
Showing other executives | DIRECTOR Age | ||
Garheng Kong | Laboratory | 45 | |
Kerrii Anderson | Laboratory | 63 | |
Dennis McGrath | DarioHealth Corp | 60 | |
Samir Kaul | Guardant Health | 44 | |
Ashley Keating | Medpace Holdings | N/A | |
JeanLuc Belingard | Laboratory | 72 | |
Robert Williams | Laboratory | 72 | |
Robert Kraft | Medpace Holdings | 47 | |
Yossi Bahagon | DarioHealth Corp | 46 | |
Glen Moller | DarioHealth Corp | N/A | |
Lawrence Best | Myriad Genetics | 68 | |
Julie Overton | BioAffinity Technologies Warran | N/A | |
Peter Neupert | Laboratory | 65 | |
Stanley Meresman | Guardant Health | 71 | |
Edward Futcher | Volitionrx | 53 | |
Fred Davenport | Medpace Holdings | 66 | |
Supraj Rajagopalan | Medpace Holdings | 38 | |
Ian Clark | Guardant Health | 57 | |
Alexander Leslie | Medpace Holdings | 35 | |
Bahija Jallal | Guardant Health | 56 | |
Habib Skaff | Volitionrx | 36 |
Management Performance
Return On Equity | 0.78 | ||||
Return On Asset | 0.14 |
Waters Leadership Team
Elected by the shareholders, the Waters' board of directors comprises two types of representatives: Waters inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Waters. The board's role is to monitor Waters' management team and ensure that shareholders' interests are well served. Waters' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Waters' outside directors are responsible for providing unbiased perspectives on the board's policies.
John Lynch, Vice President Investor Relations | ||
Gary Hendrickson, Independent Director | ||
David Terricciano, Senior Vice President - Global Operations | ||
Bryan Brokmeier, Senior Director, Investor Relations | ||
Terrance Kelly, Senior Vice President and President - TA Instruments | ||
Eugene Cassis, CFO and Sr. VP | ||
Edward Conard, Independent Director | ||
Linda Baddour, Independent Director | ||
JoAnn Reed, Advisor to CEO, Director and Member of Audit Committee | ||
Flemming Ornskov, Independent Chairman of the Board | ||
Mark Beaudouin, Senior Vice President, General Counsel, Secretary | ||
Christopher Kuebler, Independent Director | ||
Rohit Khanna, Senior Vice President - Applied Technology | ||
Christos Ross, Senior Division | ||
Michael Berendt, Independent Director | ||
Kevin Kempskie, Director PR | ||
Sherry Buck, Chief Financial Officer, Senior Vice President | ||
Michael Silveira, Chief Financial Officer, Principal Accounting Officer | ||
Belinda Hyde, Senior Vice President of Global Human Resources | ||
William Miller, Independent Director | ||
Daniel Rush, Senior Transformation | ||
Douglas Berthiaume, Chairman, CEO and Pres | ||
Pearl Huang, Independent Director | ||
Joshua Bekenstein, Independent Director | ||
Patrick Conway, Interim Resources | ||
Laurie Glimcher, Independent Director | ||
Amol Chaubal, Chief Financial Officer, Senior Vice President | ||
Christopher OConnell, Chairman of the Board, President, Chief Executive Officer | ||
Francis Kim, Senior Vice President - Global Operations | ||
Jiang Wei, Director | ||
Thomas Salice, Lead Independent Director | ||
Udit Batra, President, Chief Executive Officer, Director | ||
Michael Harrington, Senior Vice President - Global Markets | ||
Ian King, Senior Vice President - Instrument Technology | ||
Jonathan Pratt, Senior Vice President and President of TA Instruments | ||
Caspar Tudor, Director Relations | ||
Robert Carson, Senior Vice President - Corporate Development | ||
Dan Welch, Senior Vice President of Global Operations | ||
Jianqing Bennett, VP Division | ||
Kristen Garvey, Vice Communications | ||
Elizabeth Rae, Senior Vice President - Global Human Resources | ||
Arthur Caputo, Advisor | ||
John Ballbach, Independent Director | ||
Keeley Aleman, Senior Vice President General Counsel and Corporate Secretary |
Waters Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Waters a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.78 | ||||
Return On Asset | 0.14 | ||||
Profit Margin | 0.22 % | ||||
Operating Margin | 0.37 % | ||||
Current Valuation | 22.43 B | ||||
Shares Outstanding | 59.2 M | ||||
Shares Owned By Insiders | 0.36 % | ||||
Shares Owned By Institutions | 99.64 % | ||||
Number Of Shares Shorted | 3.92 M | ||||
Price To Earning | 40.43 X |
Waters Investors Sentiment
The influence of Waters' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Waters. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Waters' public news can be used to forecast risks associated with an investment in Waters. The trend in average sentiment can be used to explain how an investor holding Waters can time the market purely based on public headlines and social activities around Waters. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Waters' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Waters' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Waters' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Waters.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Waters in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Waters' short interest history, or implied volatility extrapolated from Waters options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.CLSK | CleanSpark | |
V | Visa Class A | |
CDLX | Cardlytics |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Waters. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Waters Stock please use our How to Invest in Waters guide.Note that the Waters information on this page should be used as a complementary analysis to other Waters' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Waters Stock analysis
When running Waters' price analysis, check to measure Waters' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Waters is operating at the current time. Most of Waters' value examination focuses on studying past and present price action to predict the probability of Waters' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Waters' price. Additionally, you may evaluate how the addition of Waters to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Waters' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Waters. If investors know Waters will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Waters listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Earnings Share 10.81 | Revenue Per Share 50.044 | Quarterly Revenue Growth (0.04) | Return On Assets 0.1354 |
The market value of Waters is measured differently than its book value, which is the value of Waters that is recorded on the company's balance sheet. Investors also form their own opinion of Waters' value that differs from its market value or its book value, called intrinsic value, which is Waters' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Waters' market value can be influenced by many factors that don't directly affect Waters' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Waters' value and its price as these two are different measures arrived at by different means. Investors typically determine if Waters is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Waters' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.